Ekta Bansal

Ekta Bansal

Auto-generated profile, based on publicly available information

Ekta Bansal

Section of Infectious Diseases, Department of Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, VA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in IDCases
Verified
Journal Article
Open access
HPHarsh Patolia
Harsh Patolia
EBEkta Bansal
Ekta Bansal
Fungal infections due to Phialemoniopsis spp. are rarely reported in the medical literature. We report the first two cases of fungal bursitis of the knee by Phialemoniopsis pluriloculosa, which has not been previously reported. Both patients were successfully treated with a six-month course of posaconazole.

22 September 2026 in Infectious Diseases in Clinical Practice
Verified
Journal Article
Closed access
CPChristopher J Peterson
Christopher J Peterson
MTMamata Reddy Tokala
Mamata Reddy Tokala
RNRuth Ndolo
Ruth Ndolo
CSChristopher Stocki
Christopher Stocki
SSSydney Stayrook
Sydney Stayrook
TFTasaduq Fazili
Tasaduq Fazili
Background: Staphylococcus aureus bacteremia is a common yet serious infection with high morbidity and mortality. This study evaluated 18F-FDG PET-CT scan in regards to improving 30- and 90-day mortality in patients with S. aureus bacteremia. Methods: We retrospectively identified hospitalized adults with S. aureus bacteremia who underwent 18F-FDG PET-CT between November 2020 and November 2022 and selected age-matched controls who survived at least the mean culture-to-scan interval (7 days). Results: Of 132 hospitalized patients (66 who underwent 18F-FDG PET-CT and 66 matched controls; mean age 57±17 years), PET-CT identified previously unsuspected infectious foci in 57.57% (n=38/66), prompted antibiotic-course modification in 33.33% (n=22/66), and led to source-control procedures in 25.76% (n=17/66). Crude mortality did not differ significantly: 30-day, 6.1% vs. 16.7% ( P =0.10); 90-day, 18.2% vs. 16.7% ( P =1.00) for PET-CT and control groups, respectively. Landmark-adjusted Cox models likewise showed no mortality association with PET-CT (30-day aHR 0.42, 95% CI: 0.12–1.48, P =0.18; 90-day aHR 1.71, 0.59–4.95, P =0.32). Conclusions: These results underscore the potential clinical utility of 18F-FDG PET-CT in guiding therapeutic interventions. While we did not observe a statistically significant association with mortality in adjusted analyses, 18F-FDG PET-CT scans nevertheless offer a comprehensive assessment of infection localization and disease extent, enabling clinicians to identify occult foci of infection and tailor treatment strategies accordingly. The ability of 18F-FDG PET-CT scans to detect additional sources of infection beyond the bloodstream may facilitate prompt and targeted interventions.

9 February 2025 in IDCases
Verified
Journal Article
Open access
EMEmily Miller
Emily Miller
MWMaxwell Ward
Maxwell Ward
TFTasaduq Fazili
Tasaduq Fazili
EBEkta Bansal
Ekta Bansal
Preseptal cellulitis is typically caused by nasopharyngeal bacteria and can usually be treated with empiric antibiotics. We present a case of herpes simplex virus (HSV) 1 keratitis manifesting as recurrent and treatment refractory preseptal cellulitis. This is a rare presentation that is infrequently reported in the literature. Due to the potential for permanent vision loss, it is important to consider herpes viruses as an etiology in immunocompromised patients with preseptal cellulitis not responding to standard treatment.

1 January 2014 in Journal of Research in Medical Education & Ethics
Verified
Journal Article
Closed access
PDF file
RKRitesh Kohli
Ritesh Kohli
EBEkta Bansal
Ekta Bansal
AGAshwani K Gupta
Ashwani K Gupta
PMPrithpal S Matreja
Prithpal S Matreja
We report a case of a 10-year-old male child admitted to the emergency department with a large foreign body inserted deep into his right wrist. The iron rod was all corroded and rusted, around 10-cm long and inserted deep into the wrist. It was decided to operate the child and general anaesthetic call was taken. An incision was made, extending from the volar aspect of the wrist just above iron body to the thenar crease, and the foreign body was removed with utmost care. Even in the cases of no obvious clinical signs of injury, blind removal of foreign bodies embedded deep in the wrist is inappropriate and may potentially cause more injury to the underlying structures or delay and compromise the operative exploration. During exploration, planning of the incision is crucial and the incision should be made so as to maximise the exposure to the potentially injured areas.

4 December 2021 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
TFTasaduq Fazili
Tasaduq Fazili
EBEkta Bansal
Ekta Bansal
MEMariana Gomez de la Espriella
Mariana Gomez de la Espriella
DGDorothy C Garner
Dorothy C Garner
Dalbavancin is a long acting, semisynthetic derivative of teicoplanin that is currently approved for treatment of acute bacterial skin and skin structure infections. Its efficacy and role of in the treatment of invasive infections, in particular infective endocarditis, is not well known. We reviewed the English-language literature for the use of Dalbavancin in the treatment of endocarditis due to Gram-positive organisms, using Pubmed. 15 publications were reviewed. All the publications were retrospective in nature, with relatively small numbers of patients, including a few case reports. A total of 159 patients received Dalbavancin for endocarditis. The mean age was 47 years. The main reasons for using Dalbavancin were non-feasibility of a standard outpatient regimen (mainly due to drug use) or the need for a simpler regimen. 75 patients had infection of a native valve, 44 of a prosthetic valve and 19 of a cardiac device. The type of infection for the rest of the patients was not specified. The tricuspid valve was the most frequently reported. The etiologic organisms causing endocarditis were Staphylococcus species, followed by Streptococcus species and Enterococcus species, with Staphylococcus aureus being the most common. All, but one, patients received Dalbavancin as sequential therapy, after receiving other intravenous antibiotics initially. The duration of antibiotics received prior to initiation of Dalbavancin was variable, with the median being 3 weeks. The median duration of Dalbavancin use was 2.7 weeks. The dosage regimens varied, with the more common ones using a loading dose of either 1500 mg or 1000 mg, followed by one or more weekly doses of 500 mg. The overall clinical efficacy was around 89%. Adverse events were mild, including nausea, vomiting, rash, headache and reversible acute kidney injury. None of the patients had to discontinue the drug because of adverse events. Two publications evaluated the cost effectiveness of Dalbavancin and found it to save about &9000 per patient, the saving being mainly due to reduced length of hospital stay. Dalbavancin appears to be an efficacious, safe and cost-effective option for sequential treatment of endocarditis caused by Staph aureus and other Gram-positive organisms. All Authors: No reported disclosures